1. Mechanisms underlying the activity of paederus in hepatocellular carcinoma: A network pharmacology and in vitro validation approach
   Li shan et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
2. Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer
   Rui-Jun Ju et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
3. Interference with circRNA DOCK1 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by regulating the miR-654-5p/SMAD2 axis
   Yujuan Lu et al, 2021, Molecular Medicine Reports CrossRef
4. Su Yang Decoction induces human colon carcinoma cell apoptosis by activating caspases
   Yazhong Ge et al, 2018, Oncology Letters CrossRef
5. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway
   Susu Zheng et al, 2017, Future Oncology CrossRef
6. Herbal Medicine-derived Compounds for the Prevention and Treatment of Hepatocellular Carcinoma
   Maryam Farzaneh et al, 2022, Current Cancer Therapy Reviews CrossRef
7. Traditional Chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma
   Kai-yue Tang et al, 2020, Journal of Integrative Medicine CrossRef
8. Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin
   Hua Yan et al, 2018, International Journal of Molecular Medicine CrossRef
9. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche
   Eduardo Castañón et al, 2017, Cancer Letters CrossRef